Skip to main content

Table 1 Clinical and biological characteristics of SSc patients

From: Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle

 

Systemic sclerosis (n = 19)

Age, (years)

55.2 ± 10.8

Sex (female), [n (%)]

13 (68.4%)

Disease duration, (years)

60 ± 4.5

Time of follow-up examination after baseline examination, (days)

756.6 ± 8.8

Time of baseline echocardiography between right heart catheter, (days)

6.0 ± 10.4

Body mass index (kg/m2)

24.0 ± 2.7

Arterial hypertension, [n (%)]

4 (21.1)

Smoker, [n (%)]

2 (10.5)

Raynaud’s syndrom, [n (%)]

8 (42.1)

Modified Rodnan Skin Score

8.2 ± 6.5

Anti-centromere antibodies, [n (%)]

4 (21.1)

Anti-Scl-70 antibodies, [n (%)]

7 (36.8)

Pulmonary fibrosis, [n (%)]

8 (42.1)

Impaired renal function, [n (%)]

2 (10.5)

       Invasive measurements

Cardiac output, (l/min)

5.4 ± 0.7

Cardiac index, (l/min/m2)

3.0 ± 0.4

PAP systolic, (mmHg)

27.3 ± 4.9

PAP diastolic, (mmHg)

11.2 ± 3.1

PAP mean, (mmHg)

17.7 ± 3.5

PCWP mean, (mmHg)

10.1 ± 3.6

SVR, (dyn × sec × cm-5)

2203.3 ± 787.7

PVR, (dyn × sec × cm-5)

188.3 ± 98.6

  1. Data are expressed as mean ± SD, except gender, hypertension, and except disease duration and time of follow-up examination, which are expressed as median ± SD. SSc, systemic sclerosis; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance.